🇺🇸 FDA
Patent

US 10889592

Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors

granted A61PA61P35/00A61P37/00

Quick answer

US patent 10889592 (Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors) held by Valo Early Discovery, Inc. expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Valo Early Discovery, Inc.
Grant date
Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61P, A61P35/00, A61P37/00